HEALTH
Strong Drug Sales Boost Abbott’s Third-Quarter Profit: Abbott Laboratories Inc. reported that its profit rose 11% in the third quarter, citing strong worldwide sales of pharmaceutical products. The medical supply company earned $351.3 million, or 43 cents per share, in the three months ended Sept. 30, up from $316.2 million, or 38 cents per share, for the same period last year. Sales rose 9% to $2.25 billion, from $2.06 billion. “We experienced good worldwide performance from each of our major businesses,” Chairman Duane Burnham said. “The strong sales gains this quarter, however, were driven chiefly by the worldwide growth of our pharmaceutical business.”
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.